Secure, Convenient COVID-19 Testing Results
CRL has developed self-collected testing solutions for determining COVID-19 status to help get employees safely back to work. With the CRL Clear web application, your employees can easily register their test kit, follow the self-collection instructions, and receive test results directly on their mobile device.
Here’s How It Works:
- Employee goes to crlclear.com to register their test kit.
- After completing the questionnaire and giving consent, employee follows self-collection instructions and ships sample back to lab.
- By providing a mobile number, a text notification is sent when results are ready.
- Employee clicks link in text or goes to crlclear.com to verify identity and access results.
Benefits For Employees:
Secure: Two-factor authentication process offeres quick, secure access to results from any internet connected device.
Convenient: No paper forms to fill out and return; no user or password to remember.
Fast: Online access delivers faster result reporting than calling or receiving by mail.
Flexible: Results are also reported back to employer via preferred setup, such as Web OASIS, WorkForce, HL7, API (XML)
Contact USAFact, Inc. Today 866-961-1694
CRL is a registered trademark of Clinical Reference Laboratory , INC. Rev. 111720
CRL Clear Venipuncture Serum Test: This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
CRL Rapid Response Test: This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by Clinical Reference Laboratory, Inc. located in Lenexa, Kansas. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
© 2022 USAFact, Inc.